Clinical trial
Using Blood and Stool Samples From Patients With Blood Cancer and/or Haemophagocytic Lymphohistiocytosis to Study the Influence of Host Microbial Factors on Toxicity and Survival
NCT06734624 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using Blood and Stool Samples From Patients With Blood Cancer and/or Haemophagocytic Lymphohistiocytosis to Study the Influence of Host Microbial Factors on Toxicity and Survival
- Lead sponsor
- University of Nottingham
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 1, 2025
- Completion date
- December 31, 2044
- Enrollment
- 750 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse large b cell lymphoma (dlbcl), follicular lymphoma (fl), haemophagocytic lymphohistiocytosis